Covalon Technologies

Covalon Technologies EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Covalon Technologies (COV.V) as of Oct 21, 2026 is 33.90. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 10.81 — a change of 213.54% (higher).

EV/FCF

33.90

YoY

213.54%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Covalon Technologies is 2025 33.90 . EV/FCF (Enterprise Value to Free Cash Flow) of Covalon Technologies was 2024 10.81 . It decreases by 213.54% higher compared to the previous year.

The Covalon Technologies EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-32.19 CAD
Jan 1, 2019
-13.97 CAD
Jan 1, 2020
-15.08 CAD
Jan 1, 2021
64.29 CAD
Jan 1, 2022
-4.08 CAD
Jan 1, 2023
-9.25 CAD
Jan 1, 2024
10.81 CAD
Jan 1, 2025
33.90 CAD
The Covalon Technologies EV/FCF history
YEAREV/FCFYoY
33.90+213.54%
10.81-216.81%
-9.25+127.06%
-4.08-106.34%
64.29-526.49%
-15.08+7.91%
-13.97-56.60%
-32.19-73.83%
-123.02+243.59%
-35.80+87.53%
-19.09-225.43%
15.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Covalon Technologies Stock analysis

What does Covalon Technologies do? Covalon Technologies Ltd. develops and markets patent-protected medical products including advanced wound care solutions, infection prevention technologies, and medical device coatings. The company sells products under its own brand name and also creates medical products for other medical companies through development and license contracts. Its solutions target patients requiring gentle healing with reduced infections and pain, while also serving care providers with specialized medical devices, dressings, and perioperative care systems. The company's portfolio includes antimicrobial skin protection, postoperative incision care, and scar prophylaxis solutions designed for comprehensive patient care from pre-operative to postoperative stages. Covalon's revenue streams come from direct sales of its branded products and licensing agreements with other medical companies for product development. The primary customers are healthcare providers and hospitals seeking advanced wound care and infection prevention solutions. The company focuses on medical device coatings, wound care products, and perioperative care systems as key segments within the medical technology market. Its patented technologies enable both direct product sales and collaborative development partnerships with other medical companies. The company's business model relies on two main revenue channels: selling Covalon-branded medical products directly to healthcare providers and generating income through development and license contracts with other medical companies. Its solutions are designed for patients and made for care providers, emphasizing gentle healing with less infections and pain. The company's product portfolio includes antimicrobial protection for pre-operative skin, postoperative incision care, and scar prophylaxis as part of its perioperative care offerings. Covalon Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Covalon Technologies stock

EV/FCF (Enterprise Value to Free Cash Flow) of Covalon Technologies is 33.90 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Covalon Technologies changed from 10.81 to 33.90, representing a 213.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Covalon Technologies since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Covalon Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Covalon Technologies

All Key Metrics — Covalon Technologies